News - Page 6

March 9, 2022

Next week (14^th – 20^th of March) is the 24^th Brain Awareness Week (BAW), “a global campaign to foster public enthusiasm and support for brain science” (https://www.brainawareness.org/about/).

There are many events taking place across the world, and several activities are also being proposed to help you get involved in the campaign.

In France, the “Société des Neurosciences” is hosting an extensive program, with replays of a range of conferences also being made available.

Many of the topics covered are related to themes* that our medical writing team has addressed in the form of articles and/or sketchnotes for the general public in collaboration with the “Observatoire B2V des Mémoires” (B2V Memory Observatory): https://www.synpharm.com/en/sketchnote/

*Learning, Brain and Artificial Intelligence, Brain and New Technologies, Brain and Society, Brain and Sport, Sleep, The 5 senses, Emotions, Memory, The Sick Brain.

February 28, 2022

By definition, a rare disease has a prevalence of 1/2,000. But rare diseases are numerous and would affect more than 3 million people in France, more than 300 million in the world!

Most of these diseases have no treatment. Nevertheless, many actors are mobilized in the fight against rare diseases to improve the diagnosis, care and follow-up of the patients concerned; research in this area also allows significant medical advances.

In 2021, we again had the opportunity to put our medical writing skills at the service of several rare diseases, including craniofacial microsomia, cystic fibrosis, and inherited epidermolysis bullosa.

January 25, 2022

Synergy Pharm feels particularly concerned about Neglected Tropical Diseases (NTDs) and keeps you informed about the activities of the WHO.

On Sunday 30 January 2022, the WHO will celebrate the World Neglected Tropical Diseases Day (WNTDD). The WHO activities aim to mobilize the world to defeat NTD (https://www.who.int/campaigns/world-ntd-day/world-ntd-day-2022).

December 2, 2021

On 31 January 2022, Clinical Trials Regulation (Regulation (EU) No 536/2014) will go live, repealing EU Clinical Directive (EC No 2001/20/EC) and changing how Clinical Trials are conducted in the European Union (EU).

November 9, 2021

Although hair disorders are common, their management still represents a major clinical challenge in dermatological practice despite the emergence of new diagnostic tools and new treatment options.

October 29, 2021

Today is World Psoriasis Day. It is a great opportunity to share a review of the literature on this chronic skin pathology.

October 12, 2021

October is Breast Cancer Screening Awareness Month.

More than 355,000 women were newly diagnosed with breast cancer, and nearly 92,000 women died from the disease across the EU-27 in 2020.

September 30, 2021

International Translation Day is a great opportunity to talk about the translation service offered by our medical communication agency.

September 7, 2021

A clinical study may undergo important modifications in response to extenuating circumstances such as the COVID-19 pandemic. The CONSERVE* 2021 Statement offers guidance for writing clinical study reports (CSRs) and clinical study protocols (CSPs) related to studies that undergo modifications that:

June 28, 2021

Neonatal screening, also called newborn screening (NBS), allows the early detection and clinical management of newborns with a range of health conditions.

The date for this international NBS day was chosen in honor of Dr. Robert Guthrie, whose birthday is June 28^th. In the United States in the 1960s, Dr Guthrie developed the first NBS test for phenylketonuria (PKU), using a drop of blood collected on blotting paper. This blotting paper technique is still used today in all NBS programs. The blood sample is usually collected in the first 3 days of life from the newborn’s heel, or sometimes from their hand.

Technological advances now allow the screening of up to 50 disorders from just a few dried blood spots! Most of these are congenital metabolic disorders and endocrine disorders.